Paracrinology of endometrial neuropeptides: Corticotropin-releasing hormone and opioids

Seminars in Reproductive Endocrinology

Volumn 17, Issue 1, 1999, Pages 29-38

  Gravanis, Achille ^a   Stournaras, Christos ^a   Margioris, Andrew N ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

CRH; Decidualization; Endometrium; Implantation; Opioids

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; OPIATE PEPTIDE; PRODYNORPHIN; PROENKEPHALIN; PROOPIOMELANOCORTIN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; STEROID HORMONE;

CONFERENCE PAPER; DECIDUALIZATION; ENDOMETRIUM; EPITHELIUM CELL; HUMAN; INFLAMMATION; NIDATION; PARACRINE SIGNALING; PRIORITY JOURNAL; STROMA CELL; UTERUS CONTRACTILITY;

EID: 0032976406     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016209     Document Type: Conference Paper

References (87)

1. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine peptide that stimulates secretion of corticotropin and (-endorphin. Science 1981;213:1394-1402
2. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson A. Chemical and biological characterization of corticotropin-releasing factor. Recent Prog Horm Res 1983;39:245-255
3. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986;7:351-364
4. Orth D. Corticotropin-releasing hormone in humans. Endocr Rev 1992;13:164-182
5. Usui T, Nakai Y, Tsukada T, Jingami H, Takahashi H, Fucada J. Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol Endocrinol 1988;2:871-878
6. Suda T, Tomori N, Tozawa F, Mouri T, Demoura H, Shizume K. Distribution and characterization of immuno-reactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 1984;59:861-866
7. Petrusz P, Merghenthaler I, Maderdrut L, Vigh S, Schally A. Corticotropin-releasing factor-like immunoreactivity in the vertebrate endocrine pancreas. Proc Natl Acad Sci USA 1983;80:1721-1727
8. Petrusz P, Merghenthaler I, Ordronneau P, Maderdrut L, Vigh S, Schally A. Corticotropin-releasing factor-like immunoreactivity in the gastro-entero-pancreatic endocrine system. Peptides 1984;5:71-77
9. Dammrich J, Ormanns W, Kahaly G, Schrezenmeir J. Multiple peptide hormone producing adenocarcinoma of lung with neurotensinand CRF-like immunoreactivity. Pathol Res Pract 1988;183:670-675
10. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin- releasing factor. Pharmacol Rev 1991;43:425-139
11. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW. Cloning and characterization of human urocortin. Endocrinology 1996;137:2167-2173
12. Ross PC, Kostas CM, Ramabhadran TV. A variant of the human corticotropin-releasing factor (CRF) receptor: Cloning, expression and pharmacology. Biochem Biophys Res Commun 1994;205:1836-1842
13. Hillhouse EW, Grammatopoulos D, Milton NG, Quartero HW. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metab 1993;76:736-741
14. Smets G, Van-Gompel J, Meyer C, Abs R, de-Menten Y, Kloppel G. Corticotropin-releasing hormone receptors on human pituitary cells: Autoradiography at the light microscopical level, quantification and immunocytochemistry. Prog Histochem Cytochem 1992;26:107-116
15. Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH. The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22. Genomics 1992;28:123-129
16. Xiong Y, Xie LY, Abou-Samra AB. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: Decreased coupling efficiency of human type II CRF receptor. Endocrinology 1995;136:1828-1833
17. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995;92:2969-2975
18. Kishimoto T, Pearse RV 2nd, Lin CR, Rosenfeld MG. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995;92:1108-1115
19. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995;92:836-842
20. Grigoriadis DE, Heroux JA, De Souza EB. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. Ciba Found Symp 1993;72:85-102
21. Chang CP, Pearse RV 2d, O' Connell S, Rosenfeld MG. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993;11:1187-1196
22. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993;90:8967-8973
23. Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 1975;88:295-304
24. Hughes J, Smith TW, Kosterlitz HG, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975;258:577-580
25. Lynch DR, Snyder SH. Neuropeptides: Multiple molecular forms, metabolic pathways and receptors. Annu Rev Biochem 1986;55:773-793
26. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides:multiple agonists and receptors. Nature 1977;267:495-497
27. Numa S. Opioid peptide precursors and their genes. In Gross E, Meienhofer J (eds). The peptides, Vol 6. New York: Academic Press, 1984:1
28. Chavkin C, Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature 1981;291:591-593
29. Shultz R, Wuster M, Herz A. Endogenous ligands for k-opiate receptors. Peptides 1982;3:973-979
30. Chavkin C, James J, Goldstein A. Dynorphin is a specific endogenous ligand of kappa opioid receptor. Science 1982;215:413-415
31. Atweh SF, Kuhar MJ. Distribution and significance of opioid receptors in the brain. Br Med Bull 1983;39:47-53
32. Atweh SF, Kuhar MJ. Autoradiographic localization of opiate receptors in rat brain spinal cord and lower medulla. Brain Res 1977;124:53-58
33. Atweh SF, Kuhar MJ. Autoradiographic localization of opiate receptors in rat brain stem. II. The brain stem. Brain Res 1977;129:134
34. Atweh SF, Kuhar MJ. Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res 1977;134:393-398
35. Wuster M, Schultz R, Herz A. Multiple opiate receptors in peripheral tissue preparations. Biochem Pharm 1981;30:1883-1887
36. Grino M, Chrousos G, Margioris A. The corticotropin-releasing hormone gene is expressed in human placenta. Biochem Biophys Res Commun 1987;148:1208-1213
37. Margioris AN. Corticotropin releasing hormone and the placenta and fetal membranes. In Brennecke S, Rice G (eds). Molecular aspects of placental and fetal membrane autacoids, Vol 12. Boca Raton, FL: CRC Press 1993:277
38. Linton EA, Perkins AV, Woods RJ, Eben F, Wolfe CD, Behan DP, Potter E, Vale WW, Lowry PJ. Corticotropin releasing hormone-binding protein (CRH-BP): Plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab 1993;76:260-265
39. Campbell EA, Linton EA, Wolfe CD, Scraggs PR, Jones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987;64:1054-1059
40. Frim D, Emanuel R, Robinson B, Smas C, Adler G, Majzoub J. Characterization and gestational regulation of corticotropin-releasing hormone mRNA in human placenta. J Clin Invest 1988;82:287-295
41. Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987;328:717-719
42. Robinson B, Emanuel R, Frim D, Majzoub J. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988;85:5244-5248
43. Margioris AN, Grino M, Protos P, Gold P, Chrousos G. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides. J Clin Endocrinol Metab 1988;66:922-927
44. Petraglia F, Potter E, Cameron VA, Sutton S, Behan DP, Woods RJ, Sawchenko PE, Lowry PJ, Vale W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 1993;77:919-924
45. Coukos G, Monzani A, Saletti C, Petraglia F. Noradrenaline and interleukin-1 stimulate CRF secretion from human placental cells in culture. Medicina 1988;8:441-145
46. Margioris AN, Grino M, Rabin D, Chrousos GP. Human placenta and the hypothalamic-pituitary-adrenal axis. Adv Exp Med Biol 1988;245:389-397
47. Hatzoglou A. Margioris AN. Bakogcorgou E. Gravanis A. Castanas E. Identification, characterization and localization of corticotropin-releasing hormone receptors in human placenta. Life Sci 1996;59:1871-1880
48. Quartero HW, Fry CH. Placental corticotrophin releasing factor may modulate human parturition. Placenta 1989;10:439-445
49. Sasaki A, Tempst P, Liotta AS, Margioris AN, Hood LE, Kent SB, Sato S, Shinkawa O, Yoshinaga K, Krieger DT. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J Clin Endocrinol Metab 1988;67:768-773
50. Makrigiannakis A, Zoumakis E, Margioris AN, Theodoropoulos P, Stournaras C, Gravanis A. The corticotropin-releasing hormone in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab 1995;80:185-191
51. Mastorakos G, Scopa CD, Kao LC, Vryonidou A, Friedman TC, Kattis D, Phenekos C, Rabin D, Chrousos GP. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab 1996;81:1046-1051
52. Makrigiannakis A, Margioris AN, LeGoascogne C, Zoumakis E, Nikas G, Stournaras C, Psychoyos A, Gravanis A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci 1995;57:1869-1877
53. E Zoumakis, A Makrigiannakis, A. N. Margioris, C Stournaras, A Gravanis. Endometrial corticotropin releasing hormone (CRH): Its potential autocrine-paracrine actions. Ann N Y Acad Sci 1997;828:84-95
54. Zoumakis E, Makrigiannakis A, Margioris AN, Stournaras C, Gravanis A. Corticotropin-releasing hormone (CRH) in normal and pregnant uterus: Physiological implications. Frontiers Biosci 1996;1:1-8
55. Petraglia F, Tabanelli S, Galassi C, Garuti GC, Mancini A, Genazzani A, Gurpide E. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive CRF and CRF mRNA. J Clin Endocrinol Metab 1992;74:1427-1433
56. Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology 1996;64:85-93
57. Genazzani AR, Petraglia F, Di Meo G, Santoro V, Facchineti F, Sgre A. Prostaglandin-induced mid-pregnancy abortion increases plasma and amniotic fluid levels of β-lipotropin and β-endorphin. Gynecol Obstet Invest 1987;24:23-29
58. Lemaire S, Vallete A, Chounard L, Dupuis N, Day R, Porthe G, Gros J. Purification and identification of multiple forms of dynorphin in human placenta. Neuropeptides 1983;3:181-186
59. Ahmed MS, Randall LW, Sibai B, Dass C, Fridland G, Desiderio DM, Tolun E. Identification of dynorphin (1-8) in human placenta by mass spectrometry. Life Sci 1987;40:2067-2072
60. Porthe G, Vallete A, Cros J. Kappa opiate binding sites in human placenta. Biochem Biophys Res Commun 1981;101:1-6
61. Valette A. Tafani M, Porthe G, Pontonnier G, Cros J. Placental Kappa binding sites: Interaction with dynorphin and its possible implication in hCG secretion. Life Sci 1983;33:523-531
62. Ahmed MS. Characterization of solubilized opiate receptors from human placenta. Membranes Biochem 1983;5:35-42
63. Belisle S, Petit A, Gallo-Payet N, Bellabarda D, Lehoux JG, Lemaire S. Functional opioid receptor sites in human placentas. J Clin Endocrinol Metab 1988;66:283-286
64. Makrigiannakis A, Margioris A, Markogiannakis E, Stournaras C, Gravanis A. Steroid hormones regulate the release of immunoreactive -endorphin from Ishikawa human endometrial cell line. J Clin Endocrinol Metab 1992;75:584-589
65. Gravanis A, Makrigiannakis A, Stournaras C, Margioris A. Interactions between steroid hormones and endomctrial opioid peptides. Ann NY Acad Sci 1994;734:245-257
66. Hatzoglou A. Gravanis A, Margioris AN, Zoumakis E, Castanas E. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J Clin Endocrinol Metab 1995;80:418-424
67. Karalis K, H Sano, J Redwine, S Listwark, R Wilder, Chrousos G. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254:421-424
68. Markiewitz L, Gravanis A, Schatz F, Holinka C, Gurpide E. Prostaglandin production by human endometrial adenocarcinoma. In Baulieu EE, Jacobeli S, McGuire WL (eds). Endocrinology and malignancy. Pearl River, NY: Parthenon; 1986:420
69. Simon C, Frances A, Piquette G, Danasouri I, Zurawski G, Dang W, Polan M. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994;134:521-527
70. Sheth KV, Roca GL, Al-Sedairy S, Parhar R, Hamilton G, Al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in preimplantation. Fertil Steril 1991;55:952-958
71. Engelhardt H, Croy BA, King GJ. Role of uterine immune cells in early pregnancy in pigs. J Reprod Fertil 1997;52 (Suppl):115-131
72. King A, Burrows T, Loke YW. Human uterine natural killer cells. Nat Immun 1996;15:41-52
73. Bhargava HN. Opioid peptides, receptors, and immune function. NIDA Res Monogr 1990;96:220-233
74. Ferrari A, Petraglia F, Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J Steroid Biochem Mol Biol 1995;54:251-259
75. Makrigiannakis A, Chatzaki E, Zoumakis E, Margioris A, Chrousos G, Gravanis A. Progestins stimulate the activity of the 5′-flanking region of corticotropin releasing hormone (CRH) gene in transfected stromal cells of human endometrium: Evidence for the necessity of the cAMP response element. 80th American Endocrine Society Meeting, New Orleans, USA 1998
76. DiBlasio A, Peroci-Giraldi F, Vigano P, Petraglia F, Vignall M, Cavagnini F. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab 1997;82:1594-1597
77. Brar A, Frank G, Kessler C, Cedars M, Handwerger S. Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Endocrine 1997;6:301-307
78. Psychoyos A, Nikas G, Gravanis A. The role of prostaglandins on blastocyst implantation. Hum Reprod 1995;10:30-45
79. Grunt M, Glaser J, Schmidhuber H, Pauschinger P, Born J. Effects of corticotropin-releasing factor on isolated rat heart activity. Am J Physiol 1993;264:1124-1128
80. Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: Involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995;80:2888-2893
81. Norman JE, Cameron IT. Nitric oxide in the human uterus. Rev Reprod 1996;1:61-68
82. Cameron IT, Bacon CR, Collett GP, Davenport AP. Endothelin expression in the uterus. J Steroid Biochem Mol Biol 1995;53:209-214
83. Arendt RM, Schmoeckel M, Wilbert-Lampen U, Plasse A, Heucke L, Werdan K. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: Mediation by delta opioid re-ceptor and opioid receptor antagonist-insensitive mechanisms. J Pharmacol Exp Ther 1995;272:1-7
84. Grammatopoulos D, Thompson S, Hillhouse EW. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J Clin Endocrinol Metab 1995;80:2388-2392
85. Grammatopoulos D, Stirrat GM, Williams SA, Hillhouse EW. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J Clin Endocrinol Metab 1996;81:745-751
86. Grammatopoulos D, Milton NG, Hillhouse EW. The human myometrial CRH receptor: G proteins and second messengers. Mol Cell Endocrinol 1994;99:245-250
87. Zhu Y, Pintar JE. Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. Biol Reprod 1998;59:925-932